Constantin V, Socea B, Moculescu C, Sireţeanu G, Ciofoaia V, Popa F
Clinica de Chirurgie, Spitalul Clinic "Sf. Pantelimon", Bucureşti.
Chirurgia (Bucur). 2009 May-Jun;104(3):347-50.
An aggressive array of new treatments and improvements of existing approaches for addressing morbid obesity were developed during the last two decades in response to the recognition that a new pandemic affects humanity, i.e. obesity. Initially used as a temporizing solution for other specific interventions used for obesity treatment, the endoscopic placement of an intragastric balloons has currently became in certain cases a complete therapeutic solution. Multiple studies emphasize the efficiency of this new therapeutic method, in some cases resulting in a 45 kg weight loss at the end of the monitoring period. The intragastric balloon, after endoscopic placement can be kept into position for an average period of 4-6 months. After this period, balloon extraction is recommended because of the complications that can occur with prolonged intragastric placement. This paper presents a case of pyloric obstruction by an intragastric balloon kept for 14 months. In this case, the initial approach was endoscopic, but the surgical approach offered the definitive therapeutic solution.
在过去二十年里，鉴于人们认识到一种新的流行病——肥胖症正在影响人类，一系列积极的新治疗方法以及现有治疗方法的改进被开发出来用于治疗病态肥胖。胃内球囊的内镜放置最初被用作肥胖症治疗中其他特定干预措施的临时解决方案，目前在某些情况下已成为一种完整的治疗方案。多项研究强调了这种新治疗方法的有效性，在某些情况下，监测期结束时体重减轻可达45千克。内镜放置后，胃内球囊平均可在位4至6个月。在此期间过后，由于胃内长期放置可能会出现并发症，建议取出球囊。本文介绍了一例胃内球囊留置14个月导致幽门梗阻的病例。在该病例中，最初采用的是内镜治疗方法，但手术治疗提供了最终的治疗方案。
